News
Clinical trials of valproic acid for the treatment of retinitis pigmentosa began in both the USA and Korea in late 2011. As well, a smaller shorter open-label trial was begun in Japan….
Read More about Valproic Acid as a Treatment for Retinitis Pigmentosa
In January, follow-up results from the first six months of the British choroideremia gene therapy trial were published. At the Association for Vision Research and Ophthalmology meeting today, the team led by Dr. Robert…
Read More about One Year Results of Choroideremia Gene Therapy Trial
The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…
Read More about First Gene Therapy Results for Choroideremia Suggest Cautious Optimism
1. Can you share with us what retinal eye disease you have and when you were diagnosed? The retinal disease I have is called Stargardt’s. It is when one has no central…
Read More about Youth Space Spotlight: Jessica
Can you share with us what retinal eye disease you have and when you were diagnosed? Retinitis Pigmentosa – 5 years old Did vision loss have any impact on your education choices?…
Read More about Youth Space Spotlight: Gavin
1. Can you share with us what retinal eye disease you have and when you were diagnosed? When I was 15, I was diagnosed with cataracts. I woke up one morning with…
Read More about Youth Space Spotlight: CathyJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
